Riskpilot← Back to searchSign inGet full accessSiirisco Oy
OYDissolvedY-tunnus 2529306-5Helenankuja 2-BMedical specialists activities · NACE 8622Est. 20131 employees
Revenue 2024
EUR 209K
+24% vs 2023
EBITDA margin
57.2%
+37% vs 2023
Equity ratio
96.8%
Financial strength
Net profit 2024
EUR 105K
+43% vs 2023
| Revenue | EUR 209K | +24% |
| EBITDA | EUR 120K | +37% |
| Net profit | EUR 105K | +43% |
| Total assets | EUR 750K | +8% |
| Equity | EUR 726K | +8% |
| Employees | 1 | — |
Legal name
Siirisco Oy
Y-tunnus number
2529306-5
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
1. helmikuuta 2013
Share capital
EUR 2 500
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on terveydenhoitopalvelut, erityisesti lääkäreiden vastaanottotoiminta. Lisäksi yhtiö voi omistaa ja hallita arvopapereita, osakkeita ja kiinteistöjä sekä vuokrata ja käydä niillä kauppaa.
Address
Helenankuja 2-B
Phone
+3580405091844
Email
uotilasanna@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 199 | 191 | 164 | 169 | 209 |
| Staff expenses | −65 | −57 | −60 | −66 | −72 |
| EBITDA | 118 | 121 | 88 | 87 | 120 |
| Depreciation & amort. | — | — | — | −0 | −0 |
| EBIT | 118 | 121 | 88 | 87 | 120 |
| Net financials | 22 | 35 | 121 | 4 | 12 |
| Profit before tax | 141 | 156 | 209 | 92 | 131 |
| Tax | 24 | 23 | 18 | 18 | 26 |
| Net profit | 117 | 133 | 192 | 73 | 105 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 421 | 513 | 673 | 693 | 750 |
| Equity | 401 | 502 | 654 | 675 | 726 |
| Long-term debt | — | — | — | 0 | 0 |
| Short-term debt | 20 | 11 | 20 | 18 | 24 |
| Total debt | 20 | 11 | 20 | 18 | 24 |
EBITDA margin
57.2%
This company
15.8%
Market median
+262% vs market
20202024
Equity ratio
96.8%
This company
38.2%
Market median
+153% vs market
20202024
Return on equity
14.5%
This company
18.4%
Market median
+21% vs market
20202024
Net profit margin
50.2%
This company
8.1%
Market median
+520% vs market
20202024
Asset turnover
0.28×
This company
1.12×
Market median
-75% vs market
20202024
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
SM Chief Executive Officer | Chief Executive Officer | 2015 |
MK Deputy Member | Deputy Member | 2013 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Siirisco Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sanna Maarit Uotila | Chief Executive Officer | 0 companies |
| Mika Kalevi Uotila | Deputy Member | 0 companies |